Here are what the editors at HealthDay consider to be the most important developments in Gastroenterology for September 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
High-Risk Patients Not Aware of Needed Colonoscopy Intervals
WEDNESDAY, Sept. 30, 2020 (HealthDay News) — Many patients with biopsy-confirmed advanced colorectal polyps are unaware of their need for repeat colonoscopy as well as the proper surveillance interval, according to a study recently published in the Journal of Gastroenterology and Digestive Systems.
Cancer Mortality Higher for U.S. Counties With Persistent Poverty
WEDNESDAY, Sept. 30, 2020 (HealthDay News) — U.S. counties with persistent poverty (â‰¥20 percent of residents in poverty since 1980) have higher rates of cancer mortality, according to a study published online Sept. 30 in Cancer Epidemiology, Biomarkers & Prevention.
Review IDs Dietary Factors Linked to Lower CRC Incidence
WEDNESDAY, Sept. 30, 2020 (HealthDay News) — Decreased colorectal cancer (CRC) incidence is seen in association with use of aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), magnesium, folate, and high consumption of fruits and vegetables, fiber, and dairy products, according to an umbrella review published online Sept. 28 in Gut.
Early Introduction of Gluten Linked to Decline in Celiac Disease
WEDNESDAY, Sept. 30, 2020 (HealthDay News) — Introduction of gluten from age 4 months is associated with a reduced prevalence of celiac disease (CD), according to a study published online Sept. 28 in JAMA Pediatrics.
Hospital Admissions Not Related to COVID-19 Fell in Early 2020
WEDNESDAY, Sept. 30, 2020 (HealthDay News) — Non-COVID-19 hospital admissions decreased considerably with the onset of COVID-19, with declines generally similar across patient demographic subgroups from February to April 2020, according to a report published online Sept. 24 in Health Affairs.
Proton Pump Inhibitor Use Linked to Increased T2DM Risk
TUESDAY, Sept. 29, 2020 (HealthDay News) — Regular use of proton pump inhibitors (PPIs) is associated with an increased risk for type 2 diabetes, according to a study published online Sept. 28 in Gut.
Private Health Plans Pay Hospitals 247 Percent of Medicare
MONDAY, Sept. 28, 2020 (HealthDay News) — During 2018, prices paid to hospitals by privately insured patients averaged 247 percent of what Medicare would have paid, according to a study from the RAND Corporation.
Metabolic Surgery May Cut Risk for Cardiovascular Events, Death